Home226950 • KOSDAQ
add
OliX Pharmaceuticals Inc
Previous close
₩15,690.00
Day range
₩15,190.00 - ₩15,760.00
Year range
₩8,280.00 - ₩32,750.00
Market cap
286.12B KRW
Avg Volume
446.32K
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 263.81M | -86.97% |
Operating expense | 9.64B | 37.27% |
Net income | -10.51B | -113.27% |
Net profit margin | -3.98K | -1,537.13% |
Earnings per share | — | — |
EBITDA | -8.78B | -100.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.87B | -62.18% |
Total assets | 83.61B | -17.94% |
Total liabilities | 66.82B | 10.24% |
Total equity | 16.80B | — |
Shares outstanding | 17.24M | — |
Price to book | 16.70 | — |
Return on assets | -26.81% | — |
Return on capital | -33.88% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.51B | -113.27% |
Cash from operations | -7.24B | -21.84% |
Cash from investing | 4.46B | -50.86% |
Cash from financing | -238.89M | 91.30% |
Net change in cash | -3.03B | -157.56% |
Free cash flow | -5.54B | 21.80% |
About
CEO
Founded
2010
Website
Employees
72
